Treatment of familial male precocious puberty with spironolactone and testolactone.
about
Bicalutamide and third-generation aromatase inhibitors in testotoxicosisTreatment of precocious puberty in McCune-Albright syndrome.Aromatase inhibitors in pediatrics.Management and outcome of central precocious puberty.Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.Evaluation and management of precocious puberty.Behavioral aggressiveness in boys with sexual precocityRecent Advances in the Treatment of Isosexual Precocious Puberty: Identifying all the problems.Early hyperandrogenism affects the development of hippocampal function: preliminary evidence from a functional magnetic resonance imaging study of boys with familial male precocious pubertyThe pathophysiology of precocious puberty.Advances in the management of precocious puberty.Psychiatric characterization of children with genetic causes of hyperandrogenism.17β-estradiol exposure accelerates skeletal development in Xenopus laevis tadpoles.Familial male-limited precocious puberty in neurofibromatosis type I.Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.Gender- and region-specific variations of estrogen receptor α and β expression in the growth plate of spine and limb during development and adulthood.Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)The effects of oestrogens on linear bone growth
P2860
Q33896972-90EE0CFB-0E10-4D58-8991-77D7FE64E0E7Q33988348-15EE4A36-0C12-4034-98F3-C3D17C60CE30Q34227175-CAC9C15D-56C9-4652-8D71-334FFF18914FQ34549875-45B41575-3480-4D7A-BA48-D7045383881FQ34550171-D8C7665A-0EE2-4EA6-A931-B4F7C8F785D7Q34800038-3F2BD8B5-D2B4-43A4-9A97-021606F514DFQ35967775-7B48B281-15CB-4CBE-9C29-8533961CF70AQ36283033-D738A82C-C4F8-4C7E-A8F5-617A756AFCE8Q37473918-9055F651-F555-4D8E-8C84-F0032B6C5E03Q38239846-4855F0E0-CCCE-4770-A39E-F6904FFC0D7BQ40739675-FE9A7ABB-7FBD-4796-8F84-AB94335F0929Q41555790-88BD0700-DAEA-4093-8B0C-D63BFA1D6D6FQ42911218-9DC8300E-A1D9-4F6D-B594-ED3424E7B752Q44397243-76DCCCE8-17BE-48A1-BF4A-239B2883B899Q46844248-6B67A7CE-9906-47B5-A30B-D29785A2618EQ47176345-B3281A84-593A-4A1D-8E83-F72FF3090E42Q51392503-3F9F4833-2769-4581-AE0D-F8F4CB5391CAQ55952191-09786BFC-F5BF-44D6-A9CA-42DF625EFEDCQ57420685-F95EB9A2-65DD-4B65-B646-E7DFB795B05E
P2860
Treatment of familial male precocious puberty with spironolactone and testolactone.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Treatment of familial male precocious puberty with spironolactone and testolactone.
@en
type
label
Treatment of familial male precocious puberty with spironolactone and testolactone.
@en
prefLabel
Treatment of familial male precocious puberty with spironolactone and testolactone.
@en
P2093
P1476
Treatment of familial male precocious puberty with spironolactone and testolactone.
@en
P2093
Cutler GB Jr
Kenigsberg D
Loriaux DL
Pescovitz OH
P304
P356
10.1056/NEJM198902233200805
P407
P577
1989-02-01T00:00:00Z